Startseite Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S
Artikel Open Access

Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S

  • Gamal A. El-Hiti EMAIL logo , Bakr F. Abdel-Wahab , Amany S. Hegazy und Benson M. Kariuki
Veröffentlicht/Copyright: 7. Februar 2017

Abstract

C23H16ClN5S, monoclinic, P21/n (no. 14), a = 19.8348(9) Å, b = 8.8376(3) Å, c = 23.8486(10) Å, β = 97.646(4)°, V = 4143.3(3) Å3, Z = 8, Rgt(F) = 0.0492, wRref(F2) = 0.1276, T = 293(2) K.

CCDC no.:: 1526218

The two crystallographically independent molecules of the title crystal structure are shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Colourless needle
Size:0.26 × 0.20 × 0.14 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:3.1 cm−1
Diffractometer, scan mode:SuperNova, ω-scans
2θmax, completeness:59.8°, >84% (>99 up to 50°)
N(hkl)measured, N(hkl)unique, Rint:27827, 10183, 0.029
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 661
N(param)refined:523
Programs:CrysAlisPRO [9], SHELX [10], ORTEP/WinGX [11]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.24211(11)1.5782(2)0.12747(8)0.0460(5)
C20.22457(13)1.5093(3)0.17563(10)0.0603(6)
H20.23151.40600.18110.072*
C30.19674(14)1.5939(3)0.21555(10)0.0669(7)
H30.18561.54690.24800.080*
C40.18533(13)1.7451(3)0.20824(10)0.0649(6)
H40.16591.80080.23510.078*
C50.20298(15)1.8143(3)0.16048(11)0.0717(7)
H50.19561.91750.15520.086*
C60.23132(13)1.7325(2)0.12074(10)0.0599(6)
H60.24341.78100.08890.072*
C70.29496(11)1.3636(2)0.08005(8)0.0467(5)
C80.34536(11)1.1181(2)0.08771(9)0.0489(5)
C90.37712(11)0.9760(2)0.10773(9)0.0490(5)
C100.40845(12)0.8662(2)0.07793(10)0.0554(5)
H100.41240.86570.03950.066*
C110.43206(11)0.7591(2)0.11730(9)0.0489(5)
C120.46579(11)0.6136(2)0.10954(9)0.0506(5)
C130.51383(12)0.6040(3)0.07242(10)0.0598(6)
H130.52600.69040.05390.072*
C140.54393(13)0.4663(3)0.06270(11)0.0647(6)
H140.57560.46010.03740.078*
C150.52673(13)0.3407(3)0.09049(10)0.0617(6)
C160.47931(12)0.3463(2)0.12778(10)0.0594(6)
H160.46800.25940.14640.071*
C170.44878(12)0.4832(2)0.13702(10)0.0551(5)
H170.41650.48800.16190.066*
C180.43127(11)0.7451(2)0.22323(9)0.0466(5)
C190.49753(12)0.7012(3)0.24166(10)0.0587(6)
H190.53120.71250.21840.070*
C200.51278(16)0.6402(3)0.29527(12)0.0760(8)
H200.55690.60870.30790.091*
C210.46357(18)0.6261(3)0.32967(13)0.0869(9)
H210.47440.58560.36570.104*
C220.39786(17)0.6715(3)0.31134(12)0.0820(8)
H220.36460.66300.33520.098*
C230.38130(13)0.7297(3)0.25744(11)0.0600(6)
H230.33680.75810.24450.072*
C240.69815(10)0.5923(2)0.12635(8)0.0453(5)
C250.69579(12)0.5232(3)0.17819(9)0.0560(6)
H250.70090.41890.18170.067*
C260.68579(13)0.6095(3)0.22481(10)0.0621(6)
H260.68500.56270.25970.075*
C270.67701(13)0.7630(3)0.22018(11)0.0626(6)
H270.67040.82050.25170.075*
C280.67809(13)0.8310(3)0.16841(11)0.0624(6)
H280.67150.93500.16490.075*
C290.68875(12)0.7476(2)0.12188(10)0.0534(5)
H290.68970.79540.08720.064*
C300.72772(11)0.3721(2)0.06818(8)0.0460(5)
C310.77591(11)0.1258(2)0.06346(8)0.0464(5)
C320.81204(11)−0.0165(2)0.07216(8)0.0455(5)
C330.82315(11)−0.1264(2)0.03206(9)0.0503(5)
H330.8083−0.1243−0.00660.060*
C340.86055(11)−0.2379(2)0.06173(9)0.0461(5)
C350.88346(11)−0.3838(2)0.04055(9)0.0490(5)
C360.89623(12)−0.3936(3)−0.01508(10)0.0598(6)
H360.8922−0.3074−0.03760.072*
C370.91496(13)−0.5293(3)−0.03778(11)0.0665(7)
H370.9229−0.5345−0.07530.080*
C380.92168(12)−0.6556(3)−0.00414(12)0.0615(6)
C390.90950(12)−0.6500(3)0.05095(11)0.0616(6)
H390.9145−0.73640.07340.074*
C400.88962(5)−0.51452(10)0.07312(4)0.0558(6)
H400.8803−0.51120.11030.067*
C410.90500(5)−0.25945(10)0.16613(4)0.0451(5)
C420.97155(5)−0.31118(10)0.16891(4)0.0659(6)
H420.9955−0.29720.13830.079*
C431.00226(5)−0.38380(10)0.21739(4)0.0781(8)
H431.0468−0.41840.21930.094*
C440.96644(5)−0.40469(10)0.26307(4)0.0771(8)
H440.9870−0.45330.29550.093*
C450.89990(5)−0.35295(10)0.26029(4)0.0706(7)
H450.8759−0.36690.29090.085*
C460.86918(5)−0.28033(10)0.21181(4)0.0555(5)
H460.8247−0.24570.20990.067*
N10.26926(10)1.50409(18)0.08357(7)0.0521(4)
H10.26961.55780.05350.062*
N20.31817(10)1.31961(19)0.03348(7)0.0535(5)
N30.34769(10)1.17836(19)0.03870(7)0.0553(5)
N40.38073(9)0.94219(18)0.16249(7)0.0477(4)
N50.41448(9)0.80814(18)0.16768(7)0.0461(4)
N60.70767(9)0.51543(19)0.07662(7)0.0510(4)
H6A0.69930.56860.04630.061*
N70.72575(10)0.32082(19)0.01643(7)0.0545(5)
N80.75392(10)0.17976(19)0.01409(7)0.0548(5)
N90.84089(9)−0.05410(18)0.12387(7)0.0461(4)
N100.87069(9)−0.18991(18)0.11698(7)0.0463(4)
S10.30460(3)1.22919(6)0.13349(2)0.05229(15)
S20.76268(3)0.24453(6)0.11947(2)0.04918(14)
Cl10.56410(4)0.16672(9)0.07866(3)0.0902(3)
Cl20.94636(4)−0.82648(8)−0.03139(4)0.0934(3)

Source of material

The title compound was synthesized from treatment of 2-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazole-3-carbonyl)-N-phenylhydrazinecarbothioamide with concentrated sulfuric acid in an ice bath for 1 h. This reaction mixture was left to stir at room temperature overnight, poured into cooled water and then neutralized with an aqueous sodium hydroxide solution. The solid formed was filtered, dried and recrystallized from dimethylformamide to give needle-shaped colourless crystals of the title compound (Mp. 212–213 °C) [1].

Experimental details

All hydrogen atoms were placed in calculated positions and refined using a riding model. N—H bonds were fixed at 0.86 Å, with displacement parameters 1.2Ueq(N). Aromatic C—H distances were set to 0.93 Å and their U(iso) set to 1.2Ueq for the atoms to which they are bonded.

Discussion

1,3,4-Thiadiazole ring systems [2, 3] are present in a number of natural products and have a wide range of pharmacological activities such as antibacterial, antifungal, anticancer, antioxidant and anticonvulsant [4], [5], [6], [7], [8].

The asymmetric unit comprises two molecules (I and II) of C23H16ClN5S with slightly different conformations. The twist angles about the bonds between the (phenylamino)-(thiadiazole)-(pyrazole)-(chlorophenyl) groups are 15.13(10)°, 10.49(13)° and 39.56(10)° respectively for one molecule and 22.11(7)°, 8.06(12)° and 30.04(8)° for the other molecule. The angle between the (pyrazole)-(phenyl) groups are 49.07(10)° for I and 52.32(9)° for II. Bond lengths and angles are all in the expected ranges. The two crystallographically independent molecules of the title crystal structure are pairwise connected by two N—H⋯N hydrogen bonds.

Acknowledgement

The project was supported by King Saud University, Deanship of Scientific Research, Research Chair.

References

1 Dawood, K. M.; Abdel-Gawad, H.; Mohamed, H. A.; Badria, F.: Synthesis, anti-HSV-1, and cytotoxic activities of some new pyrazole- and isoxazole-based heterocycles. Med. Chem. Res. 20 (2011) 912–917.10.1007/s00044-010-9420-4Suche in Google Scholar

2 Hu, Y.; Li, C.-Y.; Wang, X.-M.; Yang, Y.-H.; Zhu, H.-L.: 1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. Chem. Rev. 114 (2014) 5572–5610.10.1021/cr400131uSuche in Google Scholar PubMed

3 Matysiak, J.: Biological and pharmacological activities of 1,3,4-thiadiazole based compounds. Mini Rev. Med. Chem. 15 (2015) 762–775.10.2174/1389557515666150519104057Suche in Google Scholar PubMed

4 Shawali, A. S.: 1,3,4-Thiadiazoles of pharmacological interest: recent trends in their synthesis via tandem 1,3-dipolar cycloaddition: review. J. Adv. Res. 5 (2014) 1–17.10.1016/j.jare.2013.01.004Suche in Google Scholar PubMed PubMed Central

5 Jain, A. K.; Sharma, S.; Vaidya, A.; Ravichandran, V.; Agrawal, R. K.: 1,3,4-thiadiazole and its derivatives: a review on recent progress in biological activities. Chem. Biol. Drug Des. 81 (2013) 557–576.10.1111/cbdd.12125Suche in Google Scholar PubMed

6 Ali, T. E.; El-Kazak, A. M.: Synthesis and antimicrobial activity of some new 1,3-thiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and 1,3-thiazines incorporating acridine and 1,2,3,4-tetrahydroacridine moieties. Eur. J. Chem. 1 (2010) 6–11.10.5155/eurjchem.1.1.6-11.12Suche in Google Scholar

7 Li, S. H.; Li, G.; Huang, H. M.; Xiong, F.; Mai, X.; Kuang, B. H.; Liu, C. M.; Tu, G. G.: Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors. Pharmazie 64 (2009) 67–70.Suche in Google Scholar

8 Moise, M.; Sunel, V.; Profire, L.; Popa, M.; Desbrieres, J.; Peptu, C.: Synthesis and biological activity of some new 1,3,4-thiadiazole and 1,2,4-triazole compounds containing a phenylalanine moiety. Molecules 14 (2009) 2621–2631.10.3390/molecules14072621Suche in Google Scholar PubMed PubMed Central

9 Agilent Technologies: CrysAlisPRO Software system, version 1.171.37.35g, Agilent Technologies UK Ltd, Oxford, UK, (2014).Suche in Google Scholar

10 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

11 Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Suche in Google Scholar

Received: 2016-8-26
Accepted: 2017-1-10
Published Online: 2017-2-7
Published in Print: 2017-3-1

©2017 Gamal A. El-Hiti et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. The crystal structure of triphenylphosphineoxide – 2,5-dichloro-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione (2/1), C42H32Cl2O6P2
  3. Crystal structure of poly-[diaqua-[bis(μ2-hydroxy)-bis(μ4-3,4,5,6-tetrachlorophthalato-κ3O,O′:O′; κ2O′′:O′′′)dilanthanum(III)], C8H3Cl4LaO6
  4. Crystal structure of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)bis[1-phenyl-methanone], C32H20O2S2
  5. Crystal structure of 4a-hydroxy-9-(3,5-dibromo-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H18Br2O4
  6. Crystal structure of 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((2-methyl-1-(3-methylbenzamido)propan-2-yl)thio)acetate, C34H49NO5S
  7. Crystal structure of pyridinium bis(naphthalane-2,3-diolato-κ2O,O′)borate monohydrate, C25H20BNO5
  8. Crystal structure of 1,1′-((1E,1′E)-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-olato)nickel(II), C72H52N4O8Ni2
  9. The crystal structure of 3-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-N-isopropylpropan-1-aminium tetraphenylborate, C42H49BN2O4
  10. Crystal structure of 4-bromobenzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C28H34BrN3S
  11. Crystal structure of poly-[(μ6-benzene-1,2,4,5-tetracarboxylato)-(μ2-1,2-bis(imidazol-1-ylmethyl)benzene)dicobalt(II)], Co2C24H16N4O8
  12. Crystal structure of catena-(bis(μ2-1, 2-bis(imidazole-1-ylmethyl)benzene-κN:N′)-dichlororido-nickel(II)), C28H28Cl2N8Ni
  13. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(4-methoxyphenyl)prop-2-en-1-one, C15H16N2O3
  14. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-phenylprop-2-en-1-one, C14H14N2O2
  15. Crystal structure of (E)-2-(4-hydroxy-3-methoxybenzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H18O4
  16. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-(4-ethoxyphenyl)-3-hydroxyprop-2-en-1-one, C16H18N2O3
  17. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(p-toly)prop-2-en-1-one, C15H16N2O2
  18. Crystal structure of 1-acetyl-3-(3-chlorophenyl)-5-(4-isopropylphenyl)-4,5-dihydro-(1H)-pyrazole, C20H21ClN2O
  19. The crystal structure of 1-methyl-2,4-dinitro-5-iodoimidazole, C4H3IN4O4
  20. The crystal structure of 4-chloro-3,5-dinitroaniline, C6H4ClN3O4
  21. Crystal structure of N,N-dimethyl-N′-(2-methyl-4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)formimidamide, C14H18N4OS
  22. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis[μ3-4-chloro-2,6-bis((methylimino)methyl)phenolato-κ2N,O:O,N′]-(μ4-oxido)tetracopper(II), C28H32Cl2Cu4N4O11
  23. Crystal structure of catena-poly[diaqua-bis(μ2-ethane-1,2-diyl-bis(pyridine-3-carboxylate-κ2N:N′))copper(II)] dinitrate, C28H28CuN6O16
  24. Synthesis and crystal structure of catena-poly[(μ2-nicotinato-κ2O,O′: κ1N)-(nitrato-κ1O)-(bis(2-benzimidazol-ylmethyl)amine-κ3N,N′,N′′)lead(II)], C22H18N7O5Pb
  25. The twinned crystal structure of (4SR)-7-benzyl-2,4,8,8-tetramethyl-7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione, C16H20N4O2
  26. Crystal structure of (Z)-3-hydroxy-3-(4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one, C15H13NO3
  27. Crystal structure of 2-amino-4-(2,3-dichlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H12Cl2N2O2
  28. Crystal structure of catena-poly[(μ2-butane-1,4-diyl-bis(pyridine-3-carboxylato-κN))silver(I)] tetrafluoroborate, C16H16AgN2O4BF4
  29. Crystal structure of poly[diaqua-(1,10-phenanthroline-κ2N,N′)-(μ2-2,5-dihydroxytere-phthalato)-bis(μ4-2,5-dihydroxyterephthalato)dicerium(III)], C24H16CeN2O10
  30. Crystal structure of 5,7,4′-trihydroxy-3,8,3′-trymethoxyflavone, C18H16O8
  31. Crystal structure of N-(3,4-dichlorobenzylidene)-4-methylaniline, C14H11Cl2N
  32. Crystal structure of 4-(3-Methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C22H27NO4
  33. Crystal structure of 2-amino-4-(3-fluorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13FN2O2
  34. Crystal structure of 1,1,(3,4-dihydroxythieno[2,3-b] thiophene-2,5-diyl)bis(2-bromoethanone), C10H6Br2O4S2
  35. The crystal structure of N,N′-(4,4′-oxydibenzyl)-bisisonicotinamide 3.5 hydrate, C24H24N4O6
  36. Crystal structure of catena-poly[hexakis(μ2-chlorido)-hexakis(4-(1H-pyrazol-5-yl)pyridine-κN)tricadmium(II)], Cd3C48H42Cl6N18
  37. Crystal structure of 2-(4-(dimethylamino)phenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C21H22I1N3
  38. Crystal structure of 4-(1,3-dimethyl-2,3-dihydro-1H-perimidin-2-yl)benzonitrile, C20H17N3
  39. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis(2,2′-sulfonyldipyrazine-κ1N)dicopper(II), C24H24Cu2N8O12S2
  40. Crystal structure of 1-(4-chlorophenyl)-6,8-diphenyl-1H-pyrazolo[4,3-c]quinoline, C28H18ClN3
  41. Crystal structure of methyl 3-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-naphthoate, C24H21N3O5
  42. Crystal structure of (tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′′)-chloranilato-κO,O′-zinc(II) – methanol (1/1), C25H22Cl2N4O5Zn
  43. Crystal structure of 1,1-dimethyl-3-(4-methoxyphenyl)urea, C10H14N2O2
  44. Crystal structure of 4a-Hydroxy-9-(2-nitro-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H19NO6
  45. Crystal structure of chlorido-(η6–1-isopropyl-4-methyl benzene)-(1-(pyridin-2-yl)-N-(p-tolyl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C23H26ClF6N2PRu
  46. Crystal structure of phenyl(2-phenyl-2,3-dihydro-1H-perimidin-2-yl)methanone, C24H18N2O
  47. Crystal structure of (E)-3-methyl-4-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one, C29H23N7O
  48. Crystal structure of 2-(4-(2-butyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)piperazin-1-yl)-2-oxoethyldiethylcarbamodithioate, C27H34N4O3S2
  49. Crystal structure of poly-[diaqua-bis(μ-4,4′-bipyridine-κ2N:N′)cobalt(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2), C42H40Cl2CoN6O10S2
  50. Crystal structure of (η6-benzene)-(N-(2,6-dimethylphenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) perchlorate monohydrate, C20H20Cl2N2O5Ru
  51. Crystal structure of 4,10,16,22-tetrahydroxy-6,12,18,24-tetramethoxy-2,8,14,20-tetraethylphenylresorcin[4]arene – ethyl acetate (1/1), C68H72O10
  52. Crystal structure of chlorido-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)(η6-1-isopropyl-4-methyl benzene) ruthenium (II) tetrafluoroborate, C22H22Cl3N2BF4Ru
  53. Crystal structure of 3-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde, a rare Z′ = 3 structure, C20H17N5O
  54. Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S
  55. Crystal structure of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-N,N-dimethylformamide (1/1), C18H17NO5
  56. Crystal structure of halogen-bonded 2-chloro-1,10-phenanthroline—1,4-diiodotetrafluorobenzene (2/1), C30H14Cl2F4I2N4
  57. Crystal structure of 1-(4,4-dimethyl-2,6-dithioxo-1,3,5-triazinan-1-yl)-3-(diethylaminocarbonyl)thiourea, C11H20N6OS3
  58. Crystal structure of methyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C18H15FN2O2
  59. Crystal structure of 1,1-dimethyl-3-(4-methylphenyl)urea, C10H14N2O
  60. Crystal structure of yttrium gallium antimonide, Y5Ga1.24Sb2.77
  61. Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5
Heruntergeladen am 9.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0259/html
Button zum nach oben scrollen